February 2010 Contributors

He has more than 17 years of industry expertise and has been involved in every aspect of biocompatibility and toxicology testing from study design, to execution, to report writing. Contact him via e-mail at [email protected].

Ryszard Rokicki is author of “Detecting Nitinol Surface Inclusions.” He is owner of Electrobright (Macungie, PA). Currently, he collaborates with several medical and dental device companies on the implementation of U.S. Patent 7632390 as a finishing step for endovascular nitinol stents, titanium and nitinol bones implants, and endodontic NiTi rotary files. Reach him at [email protected].

Rahul Sathe wrote “Neurostimulation in the New Decade.” He is a senior engineer at Cambridge Consultants (Cambridge, MA), an engineering firm that designs medical devices, wireless technology, and consumer technology. His experience includes design, manufacturing, and supplier quality for implantable medical devices, specializing in cardiac rhythm management, neurostimulation, and cardiovascular devices. He has an MS from Georgia Institute of Technology and a BS from the University of Michigan in mechanical engineering. Contact him at [email protected].

Ravi Shankar is author of “10 Steps to Managing Master Data for Devices.” He is senior director of product marketing for Siperian (Foster City, CA). With more than 20 years of experience, he directs product and technical marketing activities for the Siperian Multidomain MDM Hub. Shankar is a published author on MDM and data governance. Previously, he directed product marketing, management, and business development efforts at Oracle. Shankar has an MBA from the Haas School of Business at the University of California, Berkeley. Reach him via e-mail at [email protected].

Margretha Zecchini is author of “Following the Road to Regulation.” She holds a BS in business administration from Gwynedd-Mercy College and an MS in bioscience regulatory affairs from Johns Hopkins University. Previously, she was a senior paralegal with Wyeth Pharmaceuticals. Zecchini plans to pursue graduate studies in health services research. Contact her at [email protected].